Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3602
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03412799 | Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer | ||
| NCT04524221 | PTG-100 for Patients With Celiac Disease | ||
| NCT06846606 | Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS | ||
| NCT06045000 | Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male Participants | ||
| NCT06980649 | Study of BHV-1300 in Graves' Disease | ||
| NCT03748758 | Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers | ||
| NCT03183128 | ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection | ||
| NCT04213807 | A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation | ||
| NCT00475514 | A Controlled Trial to Investigate the Efficacy and Safety of Frovatriptan to Prevent Menstrual Migraine | ||
| NCT04624633 | Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL | ||
| NCT03471767 | AXS-05 Phase II Trial on Smoking Behavior | ||
| NCT01495364 | NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction | ||
| NCT06975293 | STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas | ||
| NCT00694109 | An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia | ||
| NCT06990984 | A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) | ||
| NCT01941836 | Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients | ||
| NCT04896593 | Mobile Technology for Reducing and Preventing Adolescent Suicide | ||
| NCT07717892 | A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD | ||
| NCT05877963 | Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab | ||
| NCT05119335 | A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma | ||
| NCT01515540 | Brain Imaging of Lidoderm for Chronic Back Pain | ||
| NCT01210352 | Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | ||
| NCT02691247 | Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study) | ||
| NCT05760248 | Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity | ||
| NCT02223117 | Evaluation of the Safety and Immunogenicity of Autologous Thrombosomes® in Healthy Human Subjects; A Microdose Escalation Study (Cohorts 1 - 4) and Repeat Microdose Immunogenicity Study (Cohort 5) | ||
| NCT04786106 | Investigation of Surgery, Collagenase, and Restorex for the Improvement of Peyronie's | ||
| NCT05924152 | A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib | ||
| NCT01854658 | Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) | ||
| NCT04104685 | A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. | ||
| NCT06365840 | A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor | ||
| NCT05783089 | MSLN-targeted CAR-T Cells in Solid Tumors. | ||
| NCT06976268 | A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease | ||
| NCT05489991 | A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) | ||
| NCT01339091 | Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections | ||
| NCT00358982 | Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma | ||
| NCT03556280 | Multi-Center Study of Sensory Stimulation to Improve Brain Function | ||
| NCT04737486 | A First-in-Human Study of AV-001 in Healthy Subjects | ||
| NCT06906380 | A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies | ||
| NCT02830542 | SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence | ||
| NCT05366283 | Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation | ||
| NCT04909879 | Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome | ||
| NCT05392179 | A Study in Subjects With Retinitis Pigmentosa | ||
| NCT02634788 | Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain | ||
| NCT03863574 | Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis | ||
| NCT00528424 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT02137525 | Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain | ||
| NCT01316874 | Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) | ||
| NCT05725018 | A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients | ||
| NCT01893190 | Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage | ||
| NCT02286817 | Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder |
